Diagnosis and management of subcutaneous implantable cardioverter-defibrillator infections based on process mapping

Larry M. Baddour*, Raul Weiss, George E. Mark, Mikhael F. El-Chami, Mauro Biffi, Vincent Probst, Pier D. Lambiase, Marc A. Miller, Timothy McClernon, Linda K. Hansen, Bradley P. Knight

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Infection is a well-recognized complication of cardiovascular implantable electronic device (CIED) implantation, including the more recently available subcutaneous implantable cardioverter-defibrillator (S-ICD). Although the AHA/ACC/HRS guidelines include recommendations for S-ICD use, currently there are no clinical trial data that address the diagnosis and management of S-ICD infections. Therefore, an expert panel was convened to develop consensus on these topics. Methods: A process mapping methodology was used to achieve a primary goal – the development of consensus on the diagnosis and management of S-ICD infections. Two face-to-face meetings of panel experts were conducted to recommend useful information to clinicians in individual patient management of S-ICD infections. Results: Panel consensus of a stepwise approach in the diagnosis and management was developed to provide guidance in individual patient management. Conclusion: Achieving expert panel consensus by process mapping methodology in S-ICD infection diagnosis and management was attainable, and the results should be helpful in individual patient management.

Original languageEnglish (US)
Pages (from-to)958-965
Number of pages8
JournalPACE - Pacing and Clinical Electrophysiology
Volume43
Issue number9
DOIs
StatePublished - Sep 1 2020

Keywords

  • antibiotics
  • diagnosis
  • extraction
  • infection
  • mapping
  • subcutaneous implantable cardioverter-defibrillator

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Diagnosis and management of subcutaneous implantable cardioverter-defibrillator infections based on process mapping'. Together they form a unique fingerprint.

Cite this